Skip to main content
Premium Trial:

Request an Annual Quote

EnviroLogix Licenses Ionian's Nucleic Acid Technology

NEW YORK (GenomeWeb News) — Plant diagnostics firm EnviroLogix has licensed nucleic acid technology from Ionian Technologies that it will use in tests for the agricultural, plant pathogen, and veterinary testing markets, EnviroLogix said today.
 
Portland, Maine-based EnviroLogix, which offers on-site and lab-based immunoassays for detecting transgenic proteins, has licensed Ionian’s Nicking Enzyme Amplification Reaction (NEAR) technology under an exclusive and worldwide license and technology transfer agreement.
 
The tests will use Ionian’s isothermal amplification methods to detect DNA and RNA in less than 10 minutes with the same sensitivity as PCR-based tests, EnviroLogix said. The NEAR technology can be used to “detect single base changes between two otherwise similar sequences,” and the amplification products can be detected using both fluorescent and lateral flow methods, the firm said.
 
EnviroLogix has developed tests for detection of mold, mycotoxins, algal toxins, pesticides, and plant pathogens.
 
Financial terms of the agreement were not released.

The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.